Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
SUBMITTER: Serge Smeets
PROVIDER: E-GEOD-11771 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Blood 20080618 6
The proteasome inhibitor bortezomib is a novel anticancer drug that has shown promise in the treatment of refractory multiple myeloma. However, its clinical efficacy has been hampered by the emergence of drug-resistance phenomena, the molecular basis of which remains elusive. Toward this end, we here developed high levels (45- to 129-fold) of acquired resistance to bortezomib in human myelomonocytic THP1 cells by exposure to stepwise increasing (2.5-200 nM) concentrations of bortezomib. Study of ...[more]